0000899243-23-001157.txt : 20230106
0000899243-23-001157.hdr.sgml : 20230106
20230106134802
ACCESSION NUMBER: 0000899243-23-001157
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221230
FILED AS OF DATE: 20230106
DATE AS OF CHANGE: 20230106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Trigilio Jeffrey
CENTRAL INDEX KEY: 0001838671
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39856
FILM NUMBER: 23514529
MAIL ADDRESS:
STREET 1: C/O CULLINAN MANAGEMENT, INC.
STREET 2: ONE MAIN STREET, SUTIE 520
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cullinan Oncology, Inc.
CENTRAL INDEX KEY: 0001789972
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 813867811
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MAIN STREET
STREET 2: SUITE 1350
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-410-4650
MAIL ADDRESS:
STREET 1: ONE MAIN STREET
STREET 2: SUITE 1350
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Cullinan Management, Inc.
DATE OF NAME CHANGE: 20210107
FORMER COMPANY:
FORMER CONFORMED NAME: Cullinan Oncology, LLC
DATE OF NAME CHANGE: 20191001
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-12-30
0
0001789972
Cullinan Oncology, Inc.
CGEM
0001838671
Trigilio Jeffrey
C/O CULLINAN ONCOLOGY, INC.
ONE MAIN STREET, SUITE 1350
CAMBRIDGE
MA
02142
0
1
0
0
Chief Financial Officer
Common Stock
2022-12-30
4
A
0
201
8.97
A
41402
D
The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2021 Employee Stock Purchase Plan (the "ESPP"), for the purchase period of July 1, 2022 through December 30, 2022. This transaction is also exempt under Rule 16b-3(c).
In accordance with the ESPP, the shares were purchased based on 85% of the closing price of the Issuer's common stock on December 30, 2022.
/s/ Jeffrey Trigilio
2023-01-06